John S. McBride is a director of Eledon Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Eledon Pharmaceuticals, Inc.
2 May 23
4
Eledon Pharmaceuticals, Inc.
2 Feb 23
4
Eledon Pharmaceuticals, Inc.
2 Feb 22
4
Novus Therapeutics, Inc.
15 Sep 20
4
Novus Therapeutics, Inc.
15 Jul 19
4
Novus Therapeutics, Inc.
14 Jun 18
4
Novus Therapeutics, Inc.
5 Jul 17
4
Tokai Pharmaceuticals Inc
17 Dec 15
4
Tokai Pharmaceuticals Inc
22 Sep 15
4
Tokai Pharmaceuticals Inc
24 Jun 15
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 May 23 | ELDN Eledon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.3 | 150,437 | 346.01 k | 150,437 |